Podcasts about bronchodilator

Dr. Kelly and Dr. Jolle discuss two new articles this week, one about TMJ luxations in cats and one about lower airways diseases. Both were published in the JFMS this year!

Let’s talk about how to manage your COPD in this episode.

This is the second/concluding part of managing your COPD. Please listen to the first part before this.

Dr Martinez and colleagues discuss the importance of early diagnosis of COPD and how bronchodilation therapy can be optimized. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/934222?src=mkm_podcast_addon_934222

Visit http://morningcommutepodcast.com/COPD3 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, our experts will discuss triple bronchodilator regimens and which patients would most benefit from this therapy. 

Visit http://morningcommutepodcast.com/COPD2 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, our experts will discuss dual therapy regimens for COPD.

Samir Gupta, MD, and Donald W. Cockcroft, MD, join CHEST Podcast Moderator, Gretchen Winter, MD, to discuss the performance characteristics of spirometry with bronchodilator response testing and methacholine challenge testing in a large real-world cohort of patients with asthma. DOI: https://doi.org/10.1016/j.chest.2020.03.052

Critical Care Management of COVID-19Special Guests: Drayton Hammond, PharmD, MBA, MSc, BCPS, BCCCP, FCCMPeter Nikolos, PharmD Show Notes: https://pharmacytodose.files.wordpress.com/2020/04/covid-19-complications-show-notes.pdf Mechanical Ventilation (Drayton)08:00 – Non-COVID-19 PAD management; 11:16 – COVID-19 PAD management; 18:22 – Managing PAD drug shortages; 22:38 – Opioid conservation strategies; 26:08 – Propofol conservation strategies; 29:08 – Hypertriglyceridemia with propofol; 32:10 – Risk of PRIS; 34:30 – Ketamine; 41:05 – NMBA use and shortage; 46:00 – PPE conservation; 49:00 – Bronchodilator use for COVID-19; 50:28 – Inhaled anticoagulants; 52:46 – Inhaled pulmonary vasodilators; 54:17 – Advice for COVID-19 management Cardiovascular (Peter)67:20 – Current shortages; 71:05 – First-line vasopressor; 73:25 – Vasopressor compounding and utilization changes; 74:50 – Smart pump management; 77:15 – Vasopressor shortage management; 79:45 – Anticoagulation treatment strategy; 85:30 – Anticoagulation monitoring; 86:28 – Anticoagulation in ECMO/CRRT; 88:20 – PE causing rapid decompensation?; 90:25 – Alternate anticoagulants; 92:52 – Thrombolytics in ACS; 98:13 – Code response changes; 100:05 – ACE-I/ARB use in COVID-19; 103:41 – NSAID use in COVID-19; 105:15 – Statin use in COVID-19; 107:25 – Challenges from virtual rounding; 110:20 – Key points on COVID-19 management PharmacyToDose.Com@PharmacyToDose on Twitter/InstagramPharmacyToDose@Gmail.com

In this podcast, Spyridon Fortis, MD, talks about his research on how bronchodilator response in both forced expiratory volume in 1 second and forced vital capacity may indicate COPD-asthma overlap. More at: www.consultant360.com/pulmonology.

Generic Name epinephrine Trade Name Adrenalin, EpiPen Indication asthma and COPD exacerbations, allergic reactions, cardiac arrest, anesthesia adjunct Action Affects both beta1 and beta2 also has alpha agonist properties resulting in bronchodilation and  increases in HR and BP. Inhibits hypersensitivity… The post Epinephrine (Adrenalin, EpiPen): antiasthmatic, bronchodilator, vasopressor appeared first on NURSING.com.

Clive Page discusses the effects of a novel drug, RPL554, as a bronchodilator and anti-inflammatory drug.

A look at the two tests available for examining COPD.

Transcript -- A look at the two tests available for examining COPD.

A look at the two tests available for examining COPD.

Transcript -- A look at the two tests available for examining COPD.